Back to dashboard
All PlansCoverageMedium impact

Voluntary nationwide recall: Sucralfate

UPMC Health Plan·Pharmacy, Gastroenterology, Internal Medicine +2 more·Pharmacy
Effective date
Oct 6, 2023
We identified it
Aug 7, 2026
Days to comply

Summary

VistaPharm LLC has issued a voluntary nationwide recall of one lot of Sucralfate Oral Suspension (1 g/10 mL) due to Bacillus cereus contamination. This is a pharmacy safety alert requiring immediate notification to patients and providers who may have received the affected lot to prevent potential adverse events from contaminated anti-ulcer medication.

Action Required

Action needed
Immediately: Billing and clinical teams must identify patients who received the recalled Sucralfate lot and coordinate with providers for patient notification and alternative medication substitution. Contact pharmacy to obtain the specific lot number being recalled. Update patient records to flag the recalled medication. Inform providers to discontinue prescribing from this lot and switch patients to alternative anti-ulcer therapy. Document all communications in patient charts. No claims should be submitted for the recalled product; coordinate with pharmacy on credit/adjustment procedures if claims were already submitted for this lot.